July 22, 2020
The Ministry of Health, Labor and Welfare (MHLW) on July 20 ordered label revisions to add new adverse reaction risks for six contrast agents including Bayer Yakuhin’s Iopamiron (iopamidol). The six imaging agents will add “contrast-induced encephalopathy” to their lists...read more